Biologicals: Off Label Indication |
Conferences
eMediNexus Coverage from: 
Biologicals: Off Label Indication
Dr Brijesh Nair, Jaipur,  21 January 2019
Coronavirus Live Count Map India

remove_red_eye 919 Views
COVID-19 Vaccine Updates

Coronavirus Protocols

#Dermatology

0 Read Comments                

Biologicals are cutting edge molecules which have added to the armamentarium of the treating dermatologist. The biologicals/biosimilars available in India include TNF-a inhibitors, IL-17 inhibitors, T-cell Costimulatory blockers, B-cell depletion therapies like rituximab, IL-6R blockers (tocilizumab) and CD6 blocker (itolizumab). These molecules are currently approved in diseases like psoriasis, psoriatic arthritis, hidradenitis (TNFi all) and pemphigus and AAV (rituximab) among others. Off labe...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now